Provided by Tiger Trade Technology Pte. Ltd.

Teladoc Health Inc.

6.15
+0.05000.82%
Volume:519.33K
Turnover:3.19M
Market Cap:1.12B
PE:-6.20
High:6.20
Open:6.05
Low:6.05
Close:6.10
52wk High:9.89
52wk Low:4.40
Shares:181.65M
Float Shares:180.76M
Volume Ratio:0.59
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9925
EPS(LYR):-1.1400
ROE:-12.99%
ROA:-3.22%
PB:0.85
PE(LYR):-5.39

Loading ...

Teladoc up 5% at $6.93 after announcing Walmart Better Care Services pact

TIPRANKS
·
May 28

Stock Track | Teladoc Health Soars 6.53% Intraday on Walmart Partnership Expansion

Stock Track
·
May 28

Teladoc Health services launch on Walmart Better Care Services platform for $89 cash-pay visits

Reuters
·
May 28

Stock Track | Teladoc Health Soars 5.02% in Pre-market on Walmart Partnership Expansion

Stock Track
·
May 28

Teladoc Health - Services NOW Available Through Walmart’s Better Care Services Platform

THOMSON REUTERS
·
May 28

Teladoc price target raised to $8 from $7 at Goldman Sachs

TIPRANKS
·
May 27

Teladoc Shareholders Approve Board, Pay and Auditor

TIPRANKS
·
May 22

Teladoc Health shareholders elect directors at annual meeting

Reuters
·
May 22

BetterHelp Quality Push Puts Teladoc Mental Health Story In Focus

Simply Wall St.
·
May 20

Teladoc (TDOC) Gets a Hold from UBS

TIPRANKS
·
May 15

BetterHelp partners with Institute of Patient Safety, Quality of Virtual Care

TIPRANKS
·
May 14

Teladoc Health (TDOC) Is Up 14.9% After Narrower Q1 Loss And Cautious 2026 Outlook – What's Changed

Simply Wall St.
·
May 09

Teladoc Health Is Maintained at Neutral by Citigroup

Dow Jones
·
May 05

Barclays Sticks to Its Hold Rating for Teladoc (TDOC)

TIPRANKS
·
May 05

Teladoc Hold Rating Reaffirmed as 2026 Outlook Tightens and $6 DCF-Based Price Target Remains Unchanged

TIPRANKS
·
May 04

Stock Track | Teladoc Health Soars 5.06% Intraday on Q1 Loss Reduction and Improving Margins

Stock Track
·
May 01

Teladoc Health Q1 Loss Reduction Reinforces Bullish Margin Narrative Despite Flat Revenue

Simply Wall St.
·
May 01

Unchanged Risk Disclosures at Teladoc Raise Questions About Emerging Threats and Investor Exposure

TIPRANKS
·
May 01

Teladoc price target lowered to $5.50 from $6 at Stifel

TIPRANKS
·
Apr 30

Analysts Conflicted on These Healthcare Names: Teladoc (TDOC), Spyre Therapeutics (SYRE) and Regeneron (REGN)

TIPRANKS
·
Apr 30